Labeler
CELLTRION USA, Inc. NDC Codes
CELLTRION USA, Inc. lists 24 finished drug products in the FDA NDC Directory under NDC labeler code 72606.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Steqeyma, Avtozma, Omlyclo, Adalimumab, Denosumab-BMWO, Zymfentra, Yuflyma, Vegzelma, Stoboclo, Osenvelt
- Active ingredients
- Ustekinumab, Tocilizumab, Denosumab, Omalizumab, Bevacizumab, Infliximab-dyyb
- NDC labeler codes
- 72606
- Strengths
- Ustekinumab 45 mg/.5mL; Denosumab 60 mg/mL; Denosumab 120 mg/1.7mL; Omalizumab 75 mg/.5mL; Omalizumab 150 mg/mL; Omalizumab 300 mg/2mL; Tocilizumab 162 mg/.9mL; Tocilizumab 80 mg/4mL; Tocilizumab 200 mg/10mL; Tocilizumab 400 mg/20mL; Ustekinumab 90 mg/mL; Ustekinumab 130 mg/26mL; Infliximab-dyyb 120 mg/mL; Bevacizumab 100 mg/4mL; Bevacizumab 400 mg/16mL
- Dosage forms
- Injection, Solution, Injection, Kit
- Routes
- Subcutaneous, Intravenous
- Drug classes (FDA established)
- Interleukin-12 Antagonist, Interleukin-23 Antagonist, Interleukin-6 Receptor Antagonist, RANK Ligand Inhibitor, Anti-IgE, Vascular Endothelial Growth Factor Inhibitor, Tumor Necrosis Factor Blocker
- HCPCS / J-code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J0897 — Injection, denosumab, 1 mg, J9035 — Injection, bevacizumab, 10 mg
- Package NDCs
- 65
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Omlycloomalizumab-igec | Omalizumab 75 mg/.5mL | InjectionSubcutaneous | 72606-035 | 72606-0035-01 | — |
| Omlycloomalizumab-igec | Omalizumab 150 mg/mL | InjectionSubcutaneous | 72606-036 | 72606-0036-01 | — |
| Omlycloomalizumab-igec | Omalizumab 300 mg/2mL | InjectionSubcutaneous | 72606-054 | 72606-0054-0172606-0054-02 | — |
| Steqeymaustekinumab-stba | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 72606-060 | 72606-0060-01 | J3357 |
| Avtozmatocilizumab | Tocilizumab 162 mg/.9mL | Injection, SolutionSubcutaneous | 72606-045 | 72606-0045-0172606-0045-0272606-0045-03+3 more | — |
| Avtozmatocilizumab | Tocilizumab 80 mg/4mL | Injection, SolutionIntravenous | 72606-042 | 72606-0042-0172606-0042-02 | — |
| Avtozmatocilizumab | Tocilizumab 200 mg/10mL | Injection, SolutionIntravenous | 72606-043 | 72606-0043-0172606-0043-02 | — |
| Avtozmatocilizumab | Tocilizumab 400 mg/20mL | Injection, SolutionIntravenous | 72606-044 | 72606-0044-0172606-0044-02 | — |
| Denosumab-BMWO | Denosumab 60 mg/mL | InjectionSubcutaneous | 72606-058 | 72606-0058-01 | J0897 |
| Denosumab-BMWO | Denosumab 120 mg/1.7mL | InjectionSubcutaneous | 72606-059 | 72606-0059-01 | J0897 |
| Stoboclodenosumab-bmwo | Denosumab 60 mg/mL | InjectionSubcutaneous | 72606-037 | 72606-0037-01 | J0897 |
| Osenveltdenosumab-bmwo | Denosumab 120 mg/1.7mL | InjectionSubcutaneous | 72606-038 | 72606-0038-01 | J0897 |
| Steqeymaustekinumab-stba | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 72606-027 | 72606-0027-01 | J3357 |
| Steqeymaustekinumab-stba | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | 72606-028 | 72606-0028-01 | J3357 |
| Steqeymaustekinumab-stba | Ustekinumab 130 mg/26mL | Injection, SolutionIntravenous | 72606-029 | 72606-0029-01 | — |
| Zymfentrainfliximab-dyyb | — | Kit | 72606-025 | 72606-0025-0172606-0025-0272606-0025-03+9 more | — |
| Zymfentrainfliximab-dyyb | Infliximab-dyyb 120 mg/mL | InjectionSubcutaneous | 72606-047 | 72606-0047-01 | — |
| Adalimumabadalimumab-aaty | — | Kit | 72606-022 | 72606-0022-0172606-0022-0272606-0022-03+9 more | — |
| Adalimumabadalimumab-aaty | — | Kit | 72606-040 | 72606-0040-0172606-0040-0272606-0040-03+3 more | — |
| Adalimumabadalimumab-aaty | — | Kit | 72606-041 | 72606-0041-01 | — |
| Yuflymaadalimumab-aaty | — | Kit | 72606-023 | 72606-0023-0472606-0023-07 | — |
| Yuflymaadalimumab-aaty | — | Kit | 72606-030 | 72606-0030-0672606-0030-0972606-0030-10 | — |
| Vegzelmabevacizumab-adcd | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | 72606-011 | 72606-0011-0172606-0011-10 | J9035 |
| Vegzelmabevacizumab-adcd | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | 72606-012 | 72606-0012-0172606-0012-10 | J9035 |
CELLTRION USA, Inc.: common questions
- What is CELLTRION USA, Inc.'s NDC labeler code?
- 72606. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for CELLTRION USA, Inc.?
- Med-Code's HCPCS directory matches J3357, J0897, J9035 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.